Cargando…
Factors Associated with the Remission of Type 1 Diastolic Dysfunction after Dapagliflozin Treatment in Patients with Type 2 Diabetes
Patients with type 2 diabetes (T2DM) are at high risk of developing cardiovascular disease and heart failure (HF), both with preserved and reduced ejection fraction of the left ventricle. Previous research demonstrated that dapagliflozin treatment is associated with the remission of type 1 diastolic...
Autores principales: | Braha, Adina, Albai, Alin, Timar, Romulus, Diaconu, Laura, Vasiluță, Lucian, Cipu, Daniela, Timar, Bogdan, Sima, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700333/ https://www.ncbi.nlm.nih.gov/pubmed/33238573 http://dx.doi.org/10.3390/jcm9113779 |
Ejemplares similares
-
Predictors of Epicardial Fat Volume Decrease after Dapagliflozin Treatment in Patients with Type 2 Diabetes
por: Braha, Adina, et al.
Publicado: (2021) -
Dynamics of Epicardiac Fat and Heart Function in Type 2 Diabetic Patients Initiated with SGLT-2 Inhibitors
por: Braha, Adina, et al.
Publicado: (2019) -
Practical Applicability of the ISARIC-4C Score on Severity and Mortality due to SARS-CoV-2 Infection in Patients with Type 2 Diabetes
por: Albai, Oana, et al.
Publicado: (2022) -
Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus
por: Albai, Oana, et al.
Publicado: (2020) -
Predictors for pregnancy outcomes in Romanian women with Type 1 Diabetes Mellitus: a prospective study
por: Timar, Bogdan, et al.
Publicado: (2014)